Cyclophosphamide Effective, Not Well Tolerated in SPMSCyclophosphamide Effective, Not Well Tolerated in SPMS

Results of a randomized comparison show that cyclophosphamide reduced progression vs methylprednisolone in secondary progressive MS, but a high dropout rate may limit its usefulness. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news